168 related articles for article (PubMed ID: 33244317)
1. Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform.
Tang X; Xu P; Chen A; Deng G; Zhang S; Gao L; Dai L; Chen Q
Front Genet; 2020; 11():514363. PubMed ID: 33244317
[TBL] [Abstract][Full Text] [Related]
2. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract][Full Text] [Related]
3. An immunoscore nomogram for predicting survival in patients with oesophageal cancer.
Li G; Song Q; Cai A; Wei Z; Zhang R; Yi D; Chen J; Li F; Zhang Y; Liu L; Wu Y; Yi D
Aging (Albany NY); 2021 Mar; 13(6):8762-8776. PubMed ID: 33714960
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles for a prognostic immunoscore in gastric cancer.
Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
[TBL] [Abstract][Full Text] [Related]
5. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.
Zhao X; Liu J; Liu S; Yang F; Chen E
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689990
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
8. A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer.
Jiang W; Yu X; Dong X; Long C; Chen D; Cheng J; Yan B; Xu S; Lin Z; Chen G; Zhuo S; Yan J
Front Immunol; 2023; 14():1269700. PubMed ID: 37781377
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
[TBL] [Abstract][Full Text] [Related]
11. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
12. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
[TBL] [Abstract][Full Text] [Related]
13. Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.
Zhuge L; Huang B; Xie J; Gao Z; Zheng D; Zheng S; Xiang J; Zhang J
Cancer Manag Res; 2020; 12():12885-12894. PubMed ID: 33364836
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
15. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
Front Immunol; 2020; 11():621623. PubMed ID: 33613554
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
17. Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme.
Tang G; Yin W
Front Oncol; 2020; 10():154. PubMed ID: 32133292
[No Abstract] [Full Text] [Related]
18. A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
Wang K; Chen X; Jin C; Mo J; Jiang H; Yi B; Chen X
Aging (Albany NY); 2020 Nov; 13(1):675-693. PubMed ID: 33260154
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles for an immunoscore model in bone and soft tissue sarcoma.
Fan J; Qin X; He R; Ma J; Wei Q
Aging (Albany NY); 2021 May; 13(10):13708-13725. PubMed ID: 33946044
[TBL] [Abstract][Full Text] [Related]
20. A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma.
Zhou H; Zheng C; Huang DS
PeerJ; 2020; 8():e9658. PubMed ID: 32844062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]